Prevail Therapeutics Competitors and Similar CompaniesClear all
Y-mAbs Therapeutics's competitors and similar companies include Abliva.
 Y-mAbs Therapeutics Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets. |  Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. | |
Founding Date | Founding Date 2014 | Founding Date 2000 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations New York, US HQ Copenhagen, DK Nutley, US | Locations Lund, SE HQ |
Employees | Employees 3239% increase | Employees 950% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $87.7m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods $15m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit $72.7m (FY, 2024) | Gross profit kr497k (FY, 2024) |
Net income | Net income ($29.7m) (FY, 2024) | Net income (kr90m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 80m | Total funding raised $ 10.8m |
For sources of this data, please see the company profile
View Company Profiles
Abliva
HQ
Lund, SE
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View company